SI1446119T1 - Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada - Google Patents

Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada

Info

Publication number
SI1446119T1
SI1446119T1 SI200230311T SI200230311T SI1446119T1 SI 1446119 T1 SI1446119 T1 SI 1446119T1 SI 200230311 T SI200230311 T SI 200230311T SI 200230311 T SI200230311 T SI 200230311T SI 1446119 T1 SI1446119 T1 SI 1446119T1
Authority
SI
Slovenia
Prior art keywords
compositions
common cold
xylometazoline
ipatropium
treatment
Prior art date
Application number
SI200230311T
Other languages
English (en)
Slovenian (sl)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of SI1446119T1 publication Critical patent/SI1446119T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
SI200230311T 2001-09-18 2002-09-18 Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada SI1446119T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline
EP02765268A EP1446119B1 (en) 2001-09-18 2002-09-18 Compositions comprising ipatropium and xylometazoline for treatment of the common cold

Publications (1)

Publication Number Publication Date
SI1446119T1 true SI1446119T1 (sl) 2006-08-31

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230311T SI1446119T1 (sl) 2001-09-18 2002-09-18 Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada

Country Status (20)

Country Link
US (2) US7652030B2 (https=)
EP (2) EP1446119B1 (https=)
JP (1) JP4500045B2 (https=)
KR (1) KR100810872B1 (https=)
CN (1) CN1290502C (https=)
AT (1) ATE318601T1 (https=)
BR (1) BRPI0212586B8 (https=)
CA (1) CA2460140C (https=)
DE (1) DE60209511T2 (https=)
DK (1) DK1446119T3 (https=)
EA (1) EA008165B1 (https=)
ES (1) ES2259098T3 (https=)
HU (1) HU226527B1 (https=)
MX (1) MXPA04002500A (https=)
NO (1) NO334441B1 (https=)
NZ (1) NZ531792A (https=)
PL (1) PL208686B1 (https=)
PT (1) PT1446119E (https=)
SI (1) SI1446119T1 (https=)
WO (1) WO2003024433A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
MX2007007836A (es) * 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
US20170348230A1 (en) * 2014-12-24 2017-12-07 Jadran-Galenski Laboratorij D.D A nasal composition containing sea water as stability-improving excipient
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229880T2 (de) * 1991-11-19 2000-05-04 The University Of Virginia Patent Foundation, Charlottesville Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
ATE177941T1 (de) * 1992-12-09 1999-04-15 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
WO1998048839A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Topical nasal antiinflammatory compositions
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
BR9911351A (pt) 1998-06-18 2001-03-13 Boehringer Ingelheim Pharma Formulações farmacêuticas para aerossóis com duas ou mais substâncias ativas
AU765736B2 (en) 1999-06-22 2003-09-25 Boehringer Ingelheim International Gmbh Stable xylometazoline and oxymetazoline solution
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Also Published As

Publication number Publication date
BRPI0212586B8 (pt) 2021-05-25
PT1446119E (pt) 2006-07-31
ATE318601T1 (de) 2006-03-15
JP4500045B2 (ja) 2010-07-14
EP1446119B1 (en) 2006-03-01
JP2005505569A (ja) 2005-02-24
EP1661570A2 (en) 2006-05-31
US8450339B2 (en) 2013-05-28
KR100810872B1 (ko) 2008-03-06
WO2003024433A3 (en) 2004-06-10
BR0212586B1 (pt) 2013-11-19
KR20040049849A (ko) 2004-06-12
EA008165B1 (ru) 2007-04-27
ES2259098T3 (es) 2006-09-16
HK1067984A1 (en) 2005-04-22
PL370536A1 (en) 2005-05-30
BR0212586A (pt) 2004-10-13
EP1661570A3 (en) 2012-10-24
MXPA04002500A (es) 2004-11-22
DE60209511T2 (de) 2006-10-05
HUP0402075A3 (en) 2008-04-28
CA2460140C (en) 2009-09-01
US7652030B2 (en) 2010-01-26
HUP0402075A2 (hu) 2005-02-28
PL208686B1 (pl) 2011-05-31
HU226527B1 (hu) 2009-03-30
US20100093783A1 (en) 2010-04-15
CN1555263A (zh) 2004-12-15
US20040248924A1 (en) 2004-12-09
DE60209511D1 (de) 2006-04-27
NO334441B1 (no) 2014-03-03
DK1446119T3 (da) 2006-07-10
WO2003024433A2 (en) 2003-03-27
CA2460140A1 (en) 2003-03-27
CN1290502C (zh) 2006-12-20
NZ531792A (en) 2006-02-24
EA200400444A1 (ru) 2005-02-24
NO20041070L (no) 2004-05-18
EP1446119A2 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
SI1446119T1 (sl) Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
SI1458360T1 (sl) Pulmonalno dajanje aminoglikozidov
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
WO2004041867A3 (en) Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2001066564A3 (en) Gamma-secretase inhibitors
CA2472954A1 (en) Aza-arylpiperazines
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
MXPA03010761A (es) Combinaciones farmaceuticas.
AU2002307049A1 (en) Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
DE60322417D1 (en) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
WO2002072584A3 (en) Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
MXPA03011466A (es) Macrociclos utiles en tratamiento de enfermedades de alzheimer.
SG152257A1 (en) Topical preparation containing ambroxol
WO2002072571A3 (en) Pyridinyl pyrazoles useful for the treatment of copd
BR0212329A (pt) Métodos para tratar doença pulmonar
WO2002065989A3 (en) Aminoglycoside treatment for lysosomal storage diseases